| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.02B | +15.2% |
| R&D Expense | $269.0M | +18.0% |
| SG&A Expense | $1.19B | +3.3% |
| Operating Income | $2.82B | +17.3% |
| Interest Expense | $746.0M | +2.6% |
| Pre-tax Income | $2.21B | +12.9% |
| Income Tax | $347.0M | +66.8% |
| Net Income | $1.63B | +12.5% |
| EPS (Basic) | $2.35 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.84B | +5.2% |
| Accounts Receivable | $742.0M | +77.9% |
| Inventory | $46.0M | +12.2% |
| Current Assets | $4.83B | +12.6% |
| Total Assets | $21.92B | +6.1% |
| Current Liabilities | $4.22B | -27.2% |
| Long-term Debt | $14.66B | +38.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.02B | -5.6% |
| Capital Expenditures | $1.17B | -25.5% |
| Investing Cash Flow | -$1.22B | +22.9% |
| Financing Cash Flow | -$1.64B | +46.3% |
| Free Cash Flow | $1.85B | +13.3% |
| +19.3% |
| EPS (Diluted) | $2.35 | +19.9% |
| Total Liabilities |
| $19.99B |
| +14.2% |
| Stockholders' Equity | $1.59B | -44.9% |